Medline, Inc. (MDLN)
35.64
+0.10
(+0.27%)
USD |
NASDAQ |
Oct 07, 11:20
Medline Price to Book Value : 2.701 for Oct. 7, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 2.694 |
| October 05, 2026 | 2.713 |
| October 02, 2026 | 2.699 |
| October 01, 2026 | 2.648 |
| September 30, 2026 | 2.630 |
| September 29, 2026 | 2.651 |
| September 28, 2026 | 2.658 |
| September 25, 2026 | 2.630 |
| September 24, 2026 | 2.627 |
| September 23, 2026 | 2.600 |
| September 22, 2026 | 2.609 |
| September 21, 2026 | 2.422 |
| September 18, 2026 | 2.398 |
| September 17, 2026 | 2.434 |
| September 16, 2026 | 2.500 |
| September 15, 2026 | 2.434 |
| September 14, 2026 | 2.470 |
| September 11, 2026 | 2.465 |
| September 10, 2026 | 2.455 |
| September 09, 2026 | 2.580 |
| September 08, 2026 | 2.629 |
| September 04, 2026 | 2.773 |
| September 03, 2026 | 2.773 |
| September 02, 2026 | 2.751 |
| September 01, 2026 | 2.661 |
| Date | Value |
|---|---|
| August 31, 2026 | 2.655 |
| August 28, 2026 | 2.674 |
| August 27, 2026 | 2.626 |
| August 26, 2026 | 2.621 |
| August 25, 2026 | 2.701 |
| August 24, 2026 | 2.630 |
| August 21, 2026 | 2.596 |
| August 20, 2026 | 2.469 |
| August 19, 2026 | 2.570 |
| August 18, 2026 | 2.586 |
| August 17, 2026 | 2.643 |
| August 14, 2026 | 2.709 |
| August 13, 2026 | 2.696 |
| August 12, 2026 | 2.690 |
| August 11, 2026 | 2.656 |
| August 10, 2026 | 2.562 |
| August 07, 2026 | 2.67 |
| August 06, 2026 | 2.615 |
| August 05, 2026 | 2.779 |
| August 04, 2026 | 3.186 |
| August 03, 2026 | 3.067 |
| July 31, 2026 | 2.977 |
| July 30, 2026 | 2.965 |
| July 29, 2026 | 3.038 |
| July 28, 2026 | 3.070 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Insulet Corp. | 6.559 |
| Abbott Laboratories | 3.310 |
| AngioDynamics, Inc. | 3.525 |
| Alphatec Holdings, Inc. | -- |
| AtriCure, Inc. | 5.311 |
Price to Book Value Related Metrics
| PE Ratio | 41.80 |
| PS Ratio | 0.9815 |
| Price to Free Cash Flow | 19.01 |
| Price | 35.64 |
| Earnings Yield | 2.39% |
| Market Cap | 31.26B |
| Operating PE Ratio | 15.09 |
| Normalized PE Ratio | 26.50 |